Companion 2 Hospital Driver for Powering SynCardia Total Artificial Heart
Wins Silver at Medical Design Excellence Awards
JUNE 20, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial Heart in the hospital, was selected as the Silver Winner in the Critical-Care and Emergency Medicine Products category of the Medical Design Excellence Awards (MDEA) held on June 19 in Philadelphia...
U.S. News & World Report Honors 7 SynCardia Certified Centers
Among "Best Children's Hospitals" for Cardiology and Heart Surgery
JUNE 13, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named seven SynCardia Certified Centers among the nation's "Best Children's Hospitals" for cardiology and heart surgery in its annual rankings for 2013-2014...
Former Semi-Pro Arena Football Player Bridged to Heart Transplant
with the SynCardia Total Artificial Heart
May 30, 2013
When Justin Ryder, 35, was discharged from University of Arizona Medical Center in Tucson on May 20, he had a new donor heart beating in his chest and a new baby boy waiting for him at home in Las Vegas, his heart transplant made possible by 83 days of life with the SynCardia temporary Total Artificial Heart...
Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition
May 23, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the Glasgow Science Centre in Scotland, which boasts more than 380,000 visitors annually, is featuring the SynCardia temporary Total Artificial Heart powered by the Freedom® portable driver as part of its $3 million Bodyworks Exhibition, one of the most advanced exhibitions of its kind...
SynCardia Co-Founder Honored with Pioneer in Transplantation Award at ISHLT
May 16, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that world-renowned heart surgeon and SynCardia co-founder Jack G. Copeland, MD, was awarded the prestigious Pioneer in Transplantation Award at the annual meeting of the International Society of Heart & Lung Transplantation (ISHLT) on April 25 in Montreal...
Ochsner Medical Center Implants 1st SynCardia Total Artificial Heart in Gulf South Region*
May 9, 2013
When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left... until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart...
*Ochsner defines the Gulf South Region as the area extending from Louisiana to the Florida Panhandle
SynCardia's Freedom® Portable Driver Selected as Silver Winner at Edison Awards
May 2, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Freedom® portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, was named the 2013 Silver Winner amongst Assistive Devices in the Science/Medical category of the Edison Awards on April 25 in Chicago...
SynCardia Certified Centers Perform Record Number of Total Artificial Heart Implants During Q1 2013
April 25, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that a record 40 implants of the SynCardia temporary Total Artificial Heart were performed at 24 SynCardia Certified Centers during the quarter ended March 31, 2013...
Nebraska Medical Center Implants State's First SynCardia Total Artificial Heart
April 18, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Nebraska Medical Center in Omaha has performed the state's first implant of the SynCardia temporary Total Artificial Heart to save the life of 42-year-old Greg Rathe and bridge him to a second heart transplant...
20+ SynCardia Certified Centers to Present
Record Number of Total Artificial Heart Abstracts at ISHLT
April 11, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that more than 20 SynCardia Certified Centers representing four countries and more than 70 authors will present a record number of abstracts discussing the SynCardia temporary Total Artificial Heart at the annual meeting of the International Society for Heart & Lung Transplantation (ISHLT) being held April 24-27 in Montreal, Canada...
SynCardia's Companion 2 Driver Named a Finalist in the Medical Design Excellence Awards
April 4, 2013
SynCardia Systems, Inc., the privately-held manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial Heart in the hospital, has been selected as one of four finalists in the Critical-Care and Emergency Medicine Products category of the 15th Annual Medical Design Excellence Awards (MDEA). The winners will be announced on June 19 in Philadelphia...
Intermountain Medical Center Uses SynCardia Total Artificial Heart
to Bridge 31-Year-Old Father to a Heart Transplant
March 21, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Andrew Weaver, a 31-year-old husband and father of one who arrived at Intermountain Medical Center in Salt Lake City in grave condition, has been successfully bridged to a heart transplant with the SynCardia temporary Total Artificial Heart and discharged home...
Dr. Marvin Slepian Publishes Article in Journal of Biomechanics
on Downsizing the SynCardia temporary Total Artificial Heart
March 14, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart (TAH), announced today that Marvin J. Slepian, MD, the company's co-founder, chief scientific officer and chairman of the Science Advisory Board, has published a 10-page article in the Journal of Biomechanics (JBM) titled, "The SynCardia total artificial heart: in vivo, in vitro, and computational modeling studies"...
74-Year-Old Becomes Oldest SynCardia Total Artificial Heart Patient
to Leave the Hospital Using the Freedom® Portable Driver
March 7, 2013
For 73 years, Bob Phillips was nothing but healthy. So healthy in fact, that he hadn't seen a doctor for 25 years. He never suspected that at age 74, he would become the oldest patient in the U.S. and the first in Pennsylvania to leave the hospital without a human heart...
SynCardia's 50cc Total Artificial Heart Receives Two HUD Designations
from the FDA for Destination Therapy and Pediatric Bridge to Transplant
Feb. 28, 2013
SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration (FDA) has approved two Humanitarian Use Device (HUD) designations for the new 50cc Total Artificial Heart to be used for destination therapy and pediatric bridge to transplant. The 50cc device is a smaller version of the 70cc SynCardia temporary Total Artificial Heart, which received FDA approval as a bridge to transplant in 2004...
SynCardia Total Artificial Heart Patient with End-Stage Renal Failure
Recovers Kidney Function after Two Months of Support
Feb. 21, 2013
At only 20 years old, Tiernee Gonzalez has been battling two major diseases for most of her young life: heart failure and kidney failure. When she became the first patient at Cincinnati Children's Hospital Medical Center to receive the SynCardia temporary Total Artificial Heart on Nov. 9, her doctors hoped it would bring her one step closer to winning her battle against end-stage heart failure. What they didn't expect, was that it would also help save her one remaining kidney...
Forbes Ranks SynCardia Among "America's Most Promising Companies" for Second Straight Year
Feb. 14, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been selected by Forbes as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was ranked #69, moving up eight spots from its #77 ranking last year...
Article on the SynCardia Total Artificial Heart Published in British Journal of Hospital Medicine
Jan. 31, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today the publication of an article in the December 2012 issue of the British Journal of Hospital Medicine titled "The total artificial heart in a cardiac replacement therapy programme"...
SynCardia Sets New Records for Total Artificial Heart Implants, Revenue and Profit in 2012
Jan. 17, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today record-setting results for 2012 for implants, revenue and profit...
Home for the Holidays: 1st SynCardia Total Artificial Heart Patient Discharged from UCLA
Jan. 10, 2013
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Ronald Reagan UCLA Medical Center in Los Angeles has discharged its first patient to receive the SynCardia temporary Total Artificial Heart. Chad Washington, 35, left the hospital on Dec. 10, in time to celebrate the holidays at home with his wife and 4-year-old son using the Freedom® portable driver to power his Total Artificial Heart...
*The SynCardia temporary Total Artificial Heart was formerly known as the
SynCardia temporary CardioWest™ Total Artificial Heart.
